Literature DB >> 12502680

Determinants of fetal growth at different periods of pregnancies complicated by gestational diabetes mellitus or impaired glucose tolerance.

Ute M Schaefer-Graf1, Siri L Kjos, Omer Kilavuz, Andreas Plagemann, Martin Brauer, Joachim W Dudenhausen, Klaus Vetter.   

Abstract

OBJECTIVE: To determine maternal parameters with the strongest influence on fetal growth in different periods of pregnancies complicated by an abnormal glucose tolerance test (GTT). RESEARCH DESIGN AND METHODS: Retrospective study of 368 women with gestational diabetes mellitus (GDM; > or = 2 abnormal GTT values, n = 280) and impaired glucose tolerance (IGT; one abnormal value, n = 88) with 869 ultrasound examinations at entry to and during diabetic care. Both groups were managed comparably. Abdominal circumference (AC) > or = 90th percentile defined fetal macrosomia. Maternal historical and clinical parameters, and diagnostic and glycemic values of glucose profiles divided into five categories of 4 weeks of gestational age (GA; <24 weeks, 24 weeks/0 days to 27 weeks/6 days, 28/0-31/6, 32/0-35/6, and 36/0-40/0 [referred to as <24 GA, 24 GA, 28 GA, 32 GA, and 36 GA categories, respectively]) were tested by univariate and multiple logistic regression analysis for their ability to predict an AC > or = 90th percentile at each GA group and large-for-gestational-age (LGA) newborn. Data obtained at entry were also analyzed separately irrespective of the GA.
RESULTS: Maternal weight, glycemia after therapy, rates of fetal macrosomia, and LGA were not significantly different between GDM and IGT; thus, both groups were analyzed together. LGA in a previous pregnancy, (odds ratio [OR] 3.6; 95% CI 1.8-7.3) and prepregnancy obesity (BMI > or = 30 kg/m(2); 2.1; 1.2-3.7) independently predicted AC > or = 90th percentile at entry. When data for each GA category were analyzed, no predictors were found for <24 GA. Independent predictors for each subsequent GA category were as follows: at 24 GA, LGA history (OR 9.8); at 28 GA, LGA history (OR 4.2), and obesity (OR 3.3); at 32 GA, fasting glucose of 32 GA (OR 1.6 per 5-mg/dl increase); at 36 GA, fasting glucose of 32 GA (OR 1.6); and for LGA at birth, LGA history (OR 2.7), and obesity (OR 2.4).
CONCLUSIONS: In the late second and early third trimester, maternal BMI and LGA in a previous pregnancy appear to have the strongest influence on fetal growth, while later in the third trimester coincident with the period of maximum growth described in diabetic pregnancies, maternal glycemia predominates.

Entities:  

Mesh:

Year:  2003        PMID: 12502680     DOI: 10.2337/diacare.26.1.193

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  30 in total

1.  Englitazone administration to late pregnant rats produces delayed body growth and insulin resistance in their fetuses and neonates.

Authors:  Julio Sevillano; Inmaculada C López-Pérez; Emilio Herrera; María Del Pilar Ramos; Carlos Bocos
Journal:  Biochem J       Date:  2005-08-01       Impact factor: 3.857

2.  Antenatal predictors and body composition of large-for-gestational-age newborns: perinatal health outcomes.

Authors:  E L Donnelley; C H Raynes-Greenow; R M Turner; A E Carberry; H E Jeffery
Journal:  J Perinatol       Date:  2014-05-15       Impact factor: 2.521

3.  Being macrosomic at birth is an independent predictor of overweight in children: results from the IDEFICS study.

Authors:  Sonia Sparano; Wolfgang Ahrens; Stefaan De Henauw; Staffan Marild; Denes Molnar; Luis A Moreno; Marc Suling; Michael Tornaritis; Toomas Veidebaum; Alfonso Siani; Paola Russo
Journal:  Matern Child Health J       Date:  2013-10

4.  HbA(1c) and birthweight in women with pre-conception type 1 and type 2 diabetes: a population-based cohort study.

Authors:  S V Glinianaia; P W G Tennant; R W Bilous; J Rankin; R Bell
Journal:  Diabetologia       Date:  2012-09-27       Impact factor: 10.122

Review 5.  [Gestational diabetes].

Authors:  A Lechner; R Lohr; J Seissler
Journal:  Internist (Berl)       Date:  2011-10       Impact factor: 0.743

6.  Maternal body mass index and the risk of fetal and infant death: a cohort study from the North of England.

Authors:  P W G Tennant; J Rankin; R Bell
Journal:  Hum Reprod       Date:  2011-04-05       Impact factor: 6.918

7.  Are the Institute of Medicine weight gain targets applicable in women with gestational diabetes mellitus?

Authors:  Tang Wong; Robyn A Barnes; Glynis P Ross; Ngai W Cheung; Jeff R Flack
Journal:  Diabetologia       Date:  2016-12-09       Impact factor: 10.122

8.  Gestational diabetes, atopic dermatitis, and allergen sensitization in early childhood.

Authors:  Rajesh Kumar; Fengxiu Ouyang; Rachel E Story; Jacqueline A Pongracic; Xiumei Hong; Guoying Wang; Colleen Pearson; Kathryn Ortiz; Howard Bauchner; Xiaobin Wang
Journal:  J Allergy Clin Immunol       Date:  2009-09-06       Impact factor: 10.793

9.  Antenatal dietary and lifestyle advice for women who are overweight or obese and the effect on fetal growth and adiposity: the LIMIT randomised trial.

Authors:  R M Grivell; L N Yelland; A Deussen; C A Crowther; J M Dodd
Journal:  BJOG       Date:  2016-01       Impact factor: 6.531

10.  First-trimester fasting hyperglycemia and adverse pregnancy outcomes.

Authors:  Shlomit Riskin-Mashiah; Grace Younes; Amit Damti; Ron Auslender
Journal:  Diabetes Care       Date:  2009-06-23       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.